Experimental therapies under investigation for COVID-19

Link to article at PubMed

J Community Hosp Intern Med Perspect. 2021 Mar 23;11(2):187-193. doi: 10.1080/20009666.2021.1874093.


Coronavirus Disease 2019, caused by the virus, Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), is a pandemic first discovered in Wuhan, China which has claimed over 1.7 million lives to date across the globe as of 24 December 2020. As the virus spreads across the world affecting millions of patients, there has been a massive movement to discover readily available and effective treatment options including vaccines. One of the limiting factors in treating the disease is its varied presentation and effect in patients, ranging from asymptomatic patients to those left in intensive care units, intubated and fighting for their lives. There are numerous clinical trials and small-scale studies underway to investigate potential treatment options. However, very few studies and drugs demonstrated efficacy while many more are under investigation, leaving care teams dependent on supportive care coupled with experimental treatment options. In this review, we summarize the various treatment options explored to treat COVID-19, discussing possible the mechanisms of fighting the virus.

PMID:33889318 | PMC:PMC8043541 | DOI:10.1080/20009666.2021.1874093

Leave a Reply

Your email address will not be published. Required fields are marked *